Reuters: Judge Orders Merck Documents on Anti-Baldness Drug Propecia Unsealed
A U.S. judge granted Reuters’ request to unseal Merck & Co documents related to lawsuits over Propecia, prioritizing public access.
Plaintiffs claimed Merck didn’t fully disclose sexual dysfunction risks with Propecia. Sixteen months after Reuters’ motion, Judge Peggy Kuo ruled Merck’s arguments too weak to override access rights. Merck stated it interacted transparently with regulators and maintains Propecia is safe and effective.
In 2012, over 1,100 Propecia-related lawsuits were consolidated, with most settled in 2018 for $4.3 million. Judge Kuo disagreed with Merck’s argument that settled cases shouldn’t unseal documents.
Read the full story on Reuters: Judge Orders Merck Documents on Anti-Baldness Drug Propecia Unsealed
Learn more about PFS & PSSD
What is Post-Finasteride Syndrome?
Learn more about the devastating disease known as Post-Finasteride Syndrome.
What is Post-SSRI Sexual Dysfunction?
Gain insight on PSSD – Post-SSRI Sexual Dysfunction and it’s life-altering side effects.
